Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

[featured_image] Download Version Download 692 File Size 0.00 KB File Count 1 Create Date 1. January 2019 Last Updated 13. July 2023 Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany Attached Files FileActions40258-019-00523-1Download   Arthritis     Cost-effectiveness     Germany     Secukinumab  

[featured_image]
  • Version
  • Download 692
  • File Size 0.00 KB
  • File Count 1
  • Create Date 1. January 2019
  • Last Updated 13. July 2023

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

Attached Files

FileAction
s40258-019-00523-1Download